Nuo Therapeutics
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.91-0.710.13-0.12-0.60-2.00-83.02-0.03-19.83-7.29-49.12-2.00
Price/Sales ratio
4.653.281.352.640.6719.47N/AN/A534.5338.032.95K0.67
Price/Book Value ratio
2.26-1.030.233.94-11.35-5.59-22.41-0.0027.3822.2735.90-11.35
Price/Cash Flow ratio
-2.07-2.62-0.27-0.38-1.06-682.98-1.17K-0.23-16.18-7.30-37.65-682.98
Price/Free Cash Flow ratio
-2.01-2.50-0.27-0.38-1.06-682.98-1.17K-0.23-15.93-7.28-36.97-682.98
Price/Earnings Growth ratio
0.09-0.00-0.000.000.000.200.910.00-0.0027.580.270.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
12.76%30.78%9.84%-51.31%88.10%21.59%N/AN/A82.88%79.27%83.01%21.59%
Operating Profit Margin
-301.35%-358.95%-379.73%-2154.40%-109.78%-663.03%N/AN/A-2958.21%-520.64%-6400.20%-663.03%
Pretax Profit Margin
-243.02%-459.53%1019.57%-2077.36%-112.49%-817.42%N/AN/A-2825.6%-521.16%-6020.62%-817.42%
Net Profit Margin
-243.28%-458.76%1019.57%-2077.36%-112.49%-968.93%N/AN/A-2695.14%-521.16%-6020.62%-968.93%
Effective Tax Rate
-0.10%0.16%N/A3.70%-2.40%-18.53%-53.25%-316740828.64%4.61%N/AN/A-2.40%
Return on Assets
-33.58%-746.53%154.90%-1051.84%-158.05%-900.62%-90.96%-60.47%-99.27%-168.88%-59.58%-158.05%
Return On Equity
-118.26%144.45%174.03%-3102.01%1880.57%278.13%26.99%17.35%-138.05%-305.19%-114.67%278.13%
Return on Capital Employed
-49.01%117.67%-63.76%-3188.45%1835.29%190.32%73.29%17.35%-135.70%-263.28%-71.43%190.32%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A7.83N/A
Quick Ratio
2.500.062.711.220.790.230.220.223.982.006.630.79
Cash ratio
1.870.021.930.740.600.230.220.223.411.376.570.60
Days of Sales Outstanding
88.8432.1616.6657.875.90N/AN/AN/A300.19150.37290.095.90
Days of Inventory outstanding
30.0011.6513.8311.9056.76N/AN/AN/A4.55K606.6914.88K56.76
Operating Cycle
118.8543.8130.5069.7862.66N/AN/AN/A4.85K757.0714.95K62.66
Days of Payables Outstanding
101.2248.8772.09127.21979.321.65KN/AN/A7.55K1.14K18.77K979.32
Cash Conversion Cycle
17.62-5.05-41.59-57.43-916.66-1.65KN/AN/A-2.69K-384.94-14.81K-1.65K
Debt Ratios
Debt Ratio
0.004.94N/AN/A0.314.44N/AN/A0.020.040.184.44
Debt Equity Ratio
0.02-0.95N/AN/A-3.76-1.37N/AN/A0.030.080.22-3.76
Long-term Debt to Capitalization
0.01N/AN/AN/AN/AN/AN/AN/AN/AN/A0.08N/A
Total Debt to Capitalization
0.01-22.46N/AN/A1.363.68N/AN/A0.030.080.103.68
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-1.96KN/A
Cash Flow to Debt Ratio
-53.51-0.41N/AN/A-2.82-0.00N/AN/A-46.64-34.66-8.49-0.00
Company Equity Multiplier
3.52-0.191.122.94-11.89-0.30-0.29-0.281.391.801.22-11.89
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-2.24-1.25-4.95-6.80-0.63-0.02N/AN/A-33.01-5.20-78.54-0.02
Free Cash Flow / Operating Cash Flow Ratio
1.021.041111111.011.001.011
Cash Flow Coverage Ratio
-53.51-0.41N/AN/A-2.82-0.00N/AN/A-46.64-34.66-8.49-0.00
Short Term Coverage Ratio
N/A-0.41N/AN/A-2.82-0.00N/AN/A-46.64-34.66-38.88-0.00
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A